Selection of the most appropriate imaging modality should be performed in view of the delivered doses, required image quality and information and the clinical circumstances.

The new HDR-BT technique (group B) was associated only with minor acute and late toxicity and appears to result in better bRFS than the conventional HDR-BT technique (group A). The results must be confirmed in a prospective trial.

No abstract

The current standard MSCT protocols generally lead to higher organ doses to the head, midface and pelvis than the SSCT protocols, raising the question whether using the MSCT protocols recommended by the manufacturer can be justified. The dose parameters should be optimized to achieve an acceptable balance of dose reduction and adequate image quality.